LC-MS in drug analysis: methods and protocols
This second edition provides detailed LC-MS(/MS) procedures for the analysis of compounds of clinical and toxicological significance. Chapters detail new and updated methods for analyzing drugs focusing on advances in technology, alternate matrices, and rapidly-changing classes of drugs of abuse, co...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York, NY
Springer New York
2019
|
| Ausgabe: | 2nd ed. 2019 |
| Schriftenreihe: | Methods in Molecular Biology
1872 |
| Schlagworte: | |
| Online-Zugang: | UBR01 TUM01 URL des Erstveröffentlichers |
| Zusammenfassung: | This second edition provides detailed LC-MS(/MS) procedures for the analysis of compounds of clinical and toxicological significance. Chapters detail new and updated methods for analyzing drugs focusing on advances in technology, alternate matrices, and rapidly-changing classes of drugs of abuse, compounds pertinent to toxicology, and therapeutic agents. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, LC-MS in Drug Analysis: Methods and Protocols, Second Edition aims to ensure successful results in the further study of this vital field |
| Beschreibung: | An Introduction to Drug Testing - The Expanding Role of Mass Spectrometry -- Quantification of Eight Cannabinoids Including Cannabidiol in Human Urine Via Liquid Chromatography Tandem Mass Spectrometry -- Analysis of Benzodiazepines for Drug Facilitated Assaults and Abuse Settings (Urine) -- Targeted Opioid Screening Assay for Pain Management Using High Resolution Mass Spectrometry -- Measurement of Buprenorphine and Norbuprenorphine in Urine -- Quantitation of Tapentadol by Liquid Chromatography - Tandem Mass Spectrometry -- Therapeutic Drug Monitoring of Lacosamide by LC-MS/MS -- LC-MS/MS method for the quantification of the Leflunomide metabolite, Teriflunomide, in Human Serum/Plasma -- Analysis of Tryptic Peptides from Therapeutic Monoclonal Antibodies using LC-MS/MS -- Quantification of Methotrexate in Human Serum and Plasma by Liquid Chromatography Tandem Mass Spectrometry -- Simultaneous Determination of Tacrolimus and Cyclosporine A in Whole Blood by Ultra-Fast LC-MS/MS -- - Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS) Method to Quantify Gabapentin and Pregabalin in Urine -- The Evolving Landscape of Designer Drugs -- Analysis of Synthetic Cannabinoid Metabolites by Liquid Chromatography-Tandem Mass Spectrometry -- Quantification of Designer Opioids by Liquid Chromatography Tandem Mass Spectrometry -- Screening Analysis for Designer Stimulants by LC-MS/MS -- Drug Screening Using Liquid Chromatography Quadrupole Time of Flight (LC-QqTOF) Mass Spectrometry -- Alternate Matrices - Meconium, Cord Tissue, Hair, and Oral Fluid -- Salt-assisted Liquid-Liquid Extraction of Meconium for Analysis of Cocaine and Amphetamines by Liquid Chromatography-tandem Mass Spectrometry -- Detection of In Utero Cannabis Exposure in Umbilical Cord Tissue by A Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method -- Quantitation of Ethyl β-D-glucuronide in Human Umbilical Cord Tissue by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) -- - Analysis of Drugs in Oral Fluid using LC-MS/MS -- Determination of Cocaine and Metabolites in Dried Blood Spots by LC-MS/MS. |
| Beschreibung: | 1 Online-Ressource (X, 274 Seiten) Illustrationen |
| ISBN: | 9781493988235 |
| DOI: | 10.1007/978-1-4939-8823-5 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV047638363 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 211214s2019 |||| o||u| ||||||eng d | ||
| 020 | |a 9781493988235 |c Online |9 978-1-4939-8823-5 | ||
| 024 | 7 | |a 10.1007/978-1-4939-8823-5 |2 doi | |
| 035 | |a (ZDB-2-PRO)978-1-4939-8823-5 | ||
| 035 | |a (OCoLC)1289771627 | ||
| 035 | |a (DE-599)BVBBV047638363 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-91 | ||
| 082 | 0 | |a 615 | |
| 245 | 1 | 0 | |a LC-MS in drug analysis |b methods and protocols |c edited by Loralie J. Langman, Christine L.H. Snozek |
| 250 | |a 2nd ed. 2019 | ||
| 264 | 1 | |a New York, NY |b Springer New York |c 2019 | |
| 300 | |a 1 Online-Ressource (X, 274 Seiten) |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Methods in Molecular Biology | |
| 490 | 0 | |a 1872 | |
| 500 | |a An Introduction to Drug Testing - The Expanding Role of Mass Spectrometry -- Quantification of Eight Cannabinoids Including Cannabidiol in Human Urine Via Liquid Chromatography Tandem Mass Spectrometry -- Analysis of Benzodiazepines for Drug Facilitated Assaults and Abuse Settings (Urine) -- Targeted Opioid Screening Assay for Pain Management Using High Resolution Mass Spectrometry -- Measurement of Buprenorphine and Norbuprenorphine in Urine -- Quantitation of Tapentadol by Liquid Chromatography - Tandem Mass Spectrometry -- Therapeutic Drug Monitoring of Lacosamide by LC-MS/MS -- LC-MS/MS method for the quantification of the Leflunomide metabolite, Teriflunomide, in Human Serum/Plasma -- Analysis of Tryptic Peptides from Therapeutic Monoclonal Antibodies using LC-MS/MS -- Quantification of Methotrexate in Human Serum and Plasma by Liquid Chromatography Tandem Mass Spectrometry -- Simultaneous Determination of Tacrolimus and Cyclosporine A in Whole Blood by Ultra-Fast LC-MS/MS -- | ||
| 500 | |a - Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS) Method to Quantify Gabapentin and Pregabalin in Urine -- The Evolving Landscape of Designer Drugs -- Analysis of Synthetic Cannabinoid Metabolites by Liquid Chromatography-Tandem Mass Spectrometry -- Quantification of Designer Opioids by Liquid Chromatography Tandem Mass Spectrometry -- Screening Analysis for Designer Stimulants by LC-MS/MS -- Drug Screening Using Liquid Chromatography Quadrupole Time of Flight (LC-QqTOF) Mass Spectrometry -- Alternate Matrices - Meconium, Cord Tissue, Hair, and Oral Fluid -- Salt-assisted Liquid-Liquid Extraction of Meconium for Analysis of Cocaine and Amphetamines by Liquid Chromatography-tandem Mass Spectrometry -- Detection of In Utero Cannabis Exposure in Umbilical Cord Tissue by A Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method -- Quantitation of Ethyl β-D-glucuronide in Human Umbilical Cord Tissue by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) -- | ||
| 500 | |a - Analysis of Drugs in Oral Fluid using LC-MS/MS -- Determination of Cocaine and Metabolites in Dried Blood Spots by LC-MS/MS. | ||
| 520 | |a This second edition provides detailed LC-MS(/MS) procedures for the analysis of compounds of clinical and toxicological significance. Chapters detail new and updated methods for analyzing drugs focusing on advances in technology, alternate matrices, and rapidly-changing classes of drugs of abuse, compounds pertinent to toxicology, and therapeutic agents. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, LC-MS in Drug Analysis: Methods and Protocols, Second Edition aims to ensure successful results in the further study of this vital field | ||
| 650 | 4 | |a Pharmacology | |
| 700 | 1 | |a Langman, Loralie J. |d ca. 20./21. Jh. |0 (DE-588)1247549461 |4 edt | |
| 700 | 1 | |a Snozek, Christine L. |d ca. 20./21. Jh. |0 (DE-588)1247549674 |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-1-4939-9397-0 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4939-8823-5 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-PRO | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-033022612 | ||
| 966 | e | |u https://doi.org/10.1007/978-1-4939-8823-5 |l UBR01 |p ZDB-2-PRO |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1007/978-1-4939-8823-5 |l TUM01 |p ZDB-2-PRO |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804183090003705856 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Langman, Loralie J. ca. 20./21. Jh Snozek, Christine L. ca. 20./21. Jh |
| author2_role | edt edt |
| author2_variant | l j l lj ljl c l s cl cls |
| author_GND | (DE-588)1247549461 (DE-588)1247549674 |
| author_facet | Langman, Loralie J. ca. 20./21. Jh Snozek, Christine L. ca. 20./21. Jh |
| building | Verbundindex |
| bvnumber | BV047638363 |
| collection | ZDB-2-PRO |
| ctrlnum | (ZDB-2-PRO)978-1-4939-8823-5 (OCoLC)1289771627 (DE-599)BVBBV047638363 |
| dewey-full | 615 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615 |
| dewey-search | 615 |
| dewey-sort | 3615 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| doi_str_mv | 10.1007/978-1-4939-8823-5 |
| edition | 2nd ed. 2019 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04563nmm a2200457zc 4500</leader><controlfield tag="001">BV047638363</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">211214s2019 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781493988235</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-4939-8823-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4939-8823-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-PRO)978-1-4939-8823-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1289771627</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047638363</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">LC-MS in drug analysis</subfield><subfield code="b">methods and protocols</subfield><subfield code="c">edited by Loralie J. Langman, Christine L.H. Snozek</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">2nd ed. 2019</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Springer New York</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (X, 274 Seiten)</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Methods in Molecular Biology</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">1872</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">An Introduction to Drug Testing - The Expanding Role of Mass Spectrometry -- Quantification of Eight Cannabinoids Including Cannabidiol in Human Urine Via Liquid Chromatography Tandem Mass Spectrometry -- Analysis of Benzodiazepines for Drug Facilitated Assaults and Abuse Settings (Urine) -- Targeted Opioid Screening Assay for Pain Management Using High Resolution Mass Spectrometry -- Measurement of Buprenorphine and Norbuprenorphine in Urine -- Quantitation of Tapentadol by Liquid Chromatography - Tandem Mass Spectrometry -- Therapeutic Drug Monitoring of Lacosamide by LC-MS/MS -- LC-MS/MS method for the quantification of the Leflunomide metabolite, Teriflunomide, in Human Serum/Plasma -- Analysis of Tryptic Peptides from Therapeutic Monoclonal Antibodies using LC-MS/MS -- Quantification of Methotrexate in Human Serum and Plasma by Liquid Chromatography Tandem Mass Spectrometry -- Simultaneous Determination of Tacrolimus and Cyclosporine A in Whole Blood by Ultra-Fast LC-MS/MS -- </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a"> - Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS) Method to Quantify Gabapentin and Pregabalin in Urine -- The Evolving Landscape of Designer Drugs -- Analysis of Synthetic Cannabinoid Metabolites by Liquid Chromatography-Tandem Mass Spectrometry -- Quantification of Designer Opioids by Liquid Chromatography Tandem Mass Spectrometry -- Screening Analysis for Designer Stimulants by LC-MS/MS -- Drug Screening Using Liquid Chromatography Quadrupole Time of Flight (LC-QqTOF) Mass Spectrometry -- Alternate Matrices - Meconium, Cord Tissue, Hair, and Oral Fluid -- Salt-assisted Liquid-Liquid Extraction of Meconium for Analysis of Cocaine and Amphetamines by Liquid Chromatography-tandem Mass Spectrometry -- Detection of In Utero Cannabis Exposure in Umbilical Cord Tissue by A Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method -- Quantitation of Ethyl β-D-glucuronide in Human Umbilical Cord Tissue by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) -- </subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a"> - Analysis of Drugs in Oral Fluid using LC-MS/MS -- Determination of Cocaine and Metabolites in Dried Blood Spots by LC-MS/MS.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This second edition provides detailed LC-MS(/MS) procedures for the analysis of compounds of clinical and toxicological significance. Chapters detail new and updated methods for analyzing drugs focusing on advances in technology, alternate matrices, and rapidly-changing classes of drugs of abuse, compounds pertinent to toxicology, and therapeutic agents. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, LC-MS in Drug Analysis: Methods and Protocols, Second Edition aims to ensure successful results in the further study of this vital field</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Langman, Loralie J.</subfield><subfield code="d">ca. 20./21. Jh.</subfield><subfield code="0">(DE-588)1247549461</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Snozek, Christine L.</subfield><subfield code="d">ca. 20./21. Jh.</subfield><subfield code="0">(DE-588)1247549674</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-1-4939-9397-0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4939-8823-5</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-PRO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033022612</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4939-8823-5</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4939-8823-5</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV047638363 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T18:47:15Z |
| indexdate | 2024-07-10T09:17:54Z |
| institution | BVB |
| isbn | 9781493988235 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033022612 |
| oclc_num | 1289771627 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
| owner_facet | DE-355 DE-BY-UBR DE-91 DE-BY-TUM |
| physical | 1 Online-Ressource (X, 274 Seiten) Illustrationen |
| psigel | ZDB-2-PRO |
| publishDate | 2019 |
| publishDateSearch | 2019 |
| publishDateSort | 2019 |
| publisher | Springer New York |
| record_format | marc |
| series2 | Methods in Molecular Biology 1872 |
| spelling | LC-MS in drug analysis methods and protocols edited by Loralie J. Langman, Christine L.H. Snozek 2nd ed. 2019 New York, NY Springer New York 2019 1 Online-Ressource (X, 274 Seiten) Illustrationen txt rdacontent c rdamedia cr rdacarrier Methods in Molecular Biology 1872 An Introduction to Drug Testing - The Expanding Role of Mass Spectrometry -- Quantification of Eight Cannabinoids Including Cannabidiol in Human Urine Via Liquid Chromatography Tandem Mass Spectrometry -- Analysis of Benzodiazepines for Drug Facilitated Assaults and Abuse Settings (Urine) -- Targeted Opioid Screening Assay for Pain Management Using High Resolution Mass Spectrometry -- Measurement of Buprenorphine and Norbuprenorphine in Urine -- Quantitation of Tapentadol by Liquid Chromatography - Tandem Mass Spectrometry -- Therapeutic Drug Monitoring of Lacosamide by LC-MS/MS -- LC-MS/MS method for the quantification of the Leflunomide metabolite, Teriflunomide, in Human Serum/Plasma -- Analysis of Tryptic Peptides from Therapeutic Monoclonal Antibodies using LC-MS/MS -- Quantification of Methotrexate in Human Serum and Plasma by Liquid Chromatography Tandem Mass Spectrometry -- Simultaneous Determination of Tacrolimus and Cyclosporine A in Whole Blood by Ultra-Fast LC-MS/MS -- - Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS) Method to Quantify Gabapentin and Pregabalin in Urine -- The Evolving Landscape of Designer Drugs -- Analysis of Synthetic Cannabinoid Metabolites by Liquid Chromatography-Tandem Mass Spectrometry -- Quantification of Designer Opioids by Liquid Chromatography Tandem Mass Spectrometry -- Screening Analysis for Designer Stimulants by LC-MS/MS -- Drug Screening Using Liquid Chromatography Quadrupole Time of Flight (LC-QqTOF) Mass Spectrometry -- Alternate Matrices - Meconium, Cord Tissue, Hair, and Oral Fluid -- Salt-assisted Liquid-Liquid Extraction of Meconium for Analysis of Cocaine and Amphetamines by Liquid Chromatography-tandem Mass Spectrometry -- Detection of In Utero Cannabis Exposure in Umbilical Cord Tissue by A Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method -- Quantitation of Ethyl β-D-glucuronide in Human Umbilical Cord Tissue by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) -- - Analysis of Drugs in Oral Fluid using LC-MS/MS -- Determination of Cocaine and Metabolites in Dried Blood Spots by LC-MS/MS. This second edition provides detailed LC-MS(/MS) procedures for the analysis of compounds of clinical and toxicological significance. Chapters detail new and updated methods for analyzing drugs focusing on advances in technology, alternate matrices, and rapidly-changing classes of drugs of abuse, compounds pertinent to toxicology, and therapeutic agents. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, LC-MS in Drug Analysis: Methods and Protocols, Second Edition aims to ensure successful results in the further study of this vital field Pharmacology Langman, Loralie J. ca. 20./21. Jh. (DE-588)1247549461 edt Snozek, Christine L. ca. 20./21. Jh. (DE-588)1247549674 edt Erscheint auch als Druck-Ausgabe 978-1-4939-9397-0 https://doi.org/10.1007/978-1-4939-8823-5 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | LC-MS in drug analysis methods and protocols Pharmacology |
| title | LC-MS in drug analysis methods and protocols |
| title_auth | LC-MS in drug analysis methods and protocols |
| title_exact_search | LC-MS in drug analysis methods and protocols |
| title_exact_search_txtP | LC-MS in drug analysis methods and protocols |
| title_full | LC-MS in drug analysis methods and protocols edited by Loralie J. Langman, Christine L.H. Snozek |
| title_fullStr | LC-MS in drug analysis methods and protocols edited by Loralie J. Langman, Christine L.H. Snozek |
| title_full_unstemmed | LC-MS in drug analysis methods and protocols edited by Loralie J. Langman, Christine L.H. Snozek |
| title_short | LC-MS in drug analysis |
| title_sort | lc ms in drug analysis methods and protocols |
| title_sub | methods and protocols |
| topic | Pharmacology |
| topic_facet | Pharmacology |
| url | https://doi.org/10.1007/978-1-4939-8823-5 |
| work_keys_str_mv | AT langmanloraliej lcmsindruganalysismethodsandprotocols AT snozekchristinel lcmsindruganalysismethodsandprotocols |